Search results
Equities Analysts Issue Forecasts for Pfizer Inc.’s Q3 2025 Earnings (NYSE:PFE)
ETF DAILY NEWS· 5 hours agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Zacks Research dropped their Q3 2025 EPS estimates for Pfizer in a research ...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 21 hours agoNot only has it recently been trading at attractive levels, it's also currently sporting a fat...
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
Motley Fool via Yahoo Finance· 4 days agoPfizer stock lost nearly half its value over the past couple of years, but some of the world's most...
Pfizer (NYSE:PFE) Shares Up 2%
ETF DAILY NEWS· 23 hours agoPfizer Inc. (NYSE:PFE – Get Free Report)’s share price was up 2% during trading on Wednesday . The stock traded as high as $29.18 and ...
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 2 days agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 - Pfizer (NYSE:PFE)
Benzinga· 2 days agoPfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5...
Invest $50k In This Stock To Become A Dividend Millionaire In 10 Years
Benzinga via Yahoo Finance· 15 hours agoWarren Buffett, the most successful dividend investor of all time, owes his success to a simple yet...
Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their...
The Motley Fool· 6 days agoAre you famous enough for picking great stocks to become a billionaire money manager? The U.S....
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
Zacks via Yahoo Finance· 2 days agoThis is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first...
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 5 days agoArgus downgraded its Pfizer Inc. [PFE] rating to a Hold from a a Buy in a research...revised their coverage, including Guggenheim’s analysts, who began to cover the